Irritable Bowel Syndrome (IBS) Therapeutics Market Report

Global and China Irritable Bowel Syndrome (IBS) Therapeutics Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 26, 2022
  • PAGES：160
  • REPORT CODE：GMM1408825
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • IBS is a chronic disorder characterized by abdominal pain or discomfort associated with altered bowel function for at least three months, according to the Rome III criteria. Patients often experience relapse of symptoms over time.

    This report elaborates on the current development of the Irritable Bowel Syndrome (IBS) Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Valeant Pharmaceuticals International

    • Astellas Pharma

    • Ironwood Pharmaceuticals

    • Ardelyx

    • Sucampo Pharmaceuticals

    • Novartis

    • GlaxoSmithKline

    • Abbott Laboratories

    • Synergy Pharmaceuticals

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Blautix (Strain)

    • Bekinda (IBS-D)

    • SYN-010

    • Tenapanor

    Application:

    • Hospital

    • Research

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Irritable Bowel Syndrome (IBS) Therapeutics Industry Overview

      • 1.1.1 Irritable Bowel Syndrome (IBS) Therapeutics Market Scope and Market Segments

      • 1.1.2 Irritable Bowel Syndrome (IBS) Therapeutics Industry Characteristics

      • 1.1.3 Global and China Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Irritable Bowel Syndrome (IBS) Therapeutics Production Value and Growth Rate (2017-2028)

    • 1.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Blautix (Strain)

      • 1.2.2 Bekinda (IBS-D)

      • 1.2.3 SYN-010

      • 1.2.4 Tenapanor

    • 1.3 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Research

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Irritable Bowel Syndrome (IBS) Therapeutics Industry Porter's Five Forces Model Analysis

      • 2.2.3 Irritable Bowel Syndrome (IBS) Therapeutics Industry PEST Analysis

    • 2.3 Irritable Bowel Syndrome (IBS) Therapeutics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Irritable Bowel Syndrome (IBS) Therapeutics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Irritable Bowel Syndrome (IBS) Therapeutics Industry

    Chapter 3 Global and China Irritable Bowel Syndrome (IBS) Therapeutics Market, by Manufacturer

    • 3.1 Global and China Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Irritable Bowel Syndrome (IBS) Therapeutics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Irritable Bowel Syndrome (IBS) Therapeutics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Irritable Bowel Syndrome (IBS) Therapeutics Market Top 3 Players

    Chapter 4 Global and China Irritable Bowel Syndrome (IBS) Therapeutics Market, by Type (2017-2028)

    • 4.1 Irritable Bowel Syndrome (IBS) Therapeutics Market Trend, by Type

    • 4.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Irritable Bowel Syndrome (IBS) Therapeutics Price Trend, by Type (2017-2028)

    • 4.3 China Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Irritable Bowel Syndrome (IBS) Therapeutics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Irritable Bowel Syndrome (IBS) Therapeutics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Irritable Bowel Syndrome (IBS) Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Irritable Bowel Syndrome (IBS) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Irritable Bowel Syndrome (IBS) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Irritable Bowel Syndrome (IBS) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Irritable Bowel Syndrome (IBS) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis

    • 7.1 North America Irritable Bowel Syndrome (IBS) Therapeutics Market, by Type

    • 7.2 North America Irritable Bowel Syndrome (IBS) Therapeutics Market, by Application

    • 7.3 North America Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis and Forecast, by Country

      • 7.3.1 United States Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis

    • 8.1 Europe Irritable Bowel Syndrome (IBS) Therapeutics Market, by Type

    • 8.2 Europe Irritable Bowel Syndrome (IBS) Therapeutics Market, by Application

    • 8.3 Europe Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis and Forecast, by Country

      • 8.3.1 Germany Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis

    • 9.1 APAC Irritable Bowel Syndrome (IBS) Therapeutics Market, by Type

    • 9.2 APAC Irritable Bowel Syndrome (IBS) Therapeutics Market, by Application

    • 9.3 APAC Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis and Forecast, by Country

      • 9.3.1 China Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis

    • 10.1 Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Market, by Type

    • 10.2 Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Market, by Application

    • 10.3 Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Irritable Bowel Syndrome (IBS) Therapeutics Company Profiles

      • 11.1 Valeant Pharmaceuticals International

        • 11.1.1 Valeant Pharmaceuticals International Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Product Profiles, Application and Specification

        • 11.1.3 Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Astellas Pharma

        • 11.2.1 Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Product Profiles, Application and Specification

        • 11.2.3 Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Ironwood Pharmaceuticals

        • 11.3.1 Ironwood Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Product Profiles, Application and Specification

        • 11.3.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Ardelyx

        • 11.4.1 Ardelyx Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Product Profiles, Application and Specification

        • 11.4.3 Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Sucampo Pharmaceuticals

        • 11.5.1 Sucampo Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Product Profiles, Application and Specification

        • 11.5.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Novartis

        • 11.6.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Novartis Irritable Bowel Syndrome (IBS) Therapeutics Product Profiles, Application and Specification

        • 11.6.3 Novartis Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 GlaxoSmithKline

        • 11.7.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Product Profiles, Application and Specification

        • 11.7.3 GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Abbott Laboratories

        • 11.8.1 Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Product Profiles, Application and Specification

        • 11.8.3 Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Synergy Pharmaceuticals

        • 11.9.1 Synergy Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Product Profiles, Application and Specification

        • 11.9.3 Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Irritable Bowel Syndrome (IBS) Therapeutics Industry Investment Prospect and Risk Assessment

    • 12.1 Irritable Bowel Syndrome (IBS) Therapeutics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Irritable Bowel Syndrome (IBS) Therapeutics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size and Growth Rate of Blautix (Strain) (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size and Growth Rate of Bekinda (IBS-D) (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size and Growth Rate of SYN-010 (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size and Growth Rate of Tenapanor (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size and Growth Rate of Research (2017-2028)

    • Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Irritable Bowel Syndrome (IBS) Therapeutics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Irritable Bowel Syndrome (IBS) Therapeutics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Irritable Bowel Syndrome (IBS) Therapeutics Market Share, by Manufacturer in 2021

    • Figure Global and China Irritable Bowel Syndrome (IBS) Therapeutics Market Share, by Manufacturer in 2022

    • Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, by Type (2017-2028)

    • Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Value, by Type (2017-2028)

    • Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Price Trend, by Type (2017-2028)

    • Table China Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, by Type (2017-2028)

    • Table China Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table China Irritable Bowel Syndrome (IBS) Therapeutics Sales Value, by Type (2017-2028)

    • Table China Irritable Bowel Syndrome (IBS) Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Therapeutics Price Trend, by Type (2017-2028)

    • Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, by Application (2017-2028)

    • Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Value, by Application (2017-2028)

    • Table Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Therapeutics Sales Value Share, by Application (2017-2028)

    • Table China Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, by Application (2017-2028)

    • Table China Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table China Irritable Bowel Syndrome (IBS) Therapeutics Sales Value, by Application (2017-2028)

    • Table China Irritable Bowel Syndrome (IBS) Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Irritable Bowel Syndrome (IBS) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Irritable Bowel Syndrome (IBS) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Table North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, by Type (2017-2028)

    • Table North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, by Application (2017-2028)

    • Table North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure North America Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure United States Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure United States Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Canada Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, by Type (2017-2028)

    • Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, by Application (2017-2028)

    • Table Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Europe Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Germany Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure UK Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure UK Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure France Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure France Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Italy Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Spain Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Poland Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Russia Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table APAC Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, by Type (2017-2028)

    • Table APAC Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure APAC Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table APAC Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, by Application (2017-2028)

    • Table APAC Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure APAC Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Japan Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure India Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure India Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Irritable Bowel Syndrome (IBS) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Valeant Pharmaceuticals International Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Valeant Pharmaceuticals International Product Profiles, Application and Specification

    • Table Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma Product Profiles, Application and Specification

    • Table Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ironwood Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ironwood Pharmaceuticals Product Profiles, Application and Specification

    • Table Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ardelyx Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ardelyx Product Profiles, Application and Specification

    • Table Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sucampo Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sucampo Pharmaceuticals Product Profiles, Application and Specification

    • Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Laboratories Product Profiles, Application and Specification

    • Table Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Synergy Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Synergy Pharmaceuticals Product Profiles, Application and Specification

    • Table Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US